Trinity Biotech ADR buy StockNews.com
Start price
12.02.24
/
50%
€0.52
Target price
12.02.25
-
Performance (%)
-20.77%
End price
13.02.25
-
Summary
This prediction is currently being closed. The prediction for Trinity Biotech ADR disappoints with a performance of -20.77%. StockNews_com has a follow-up prediction for Trinity Biotech ADR, but this time predicts that Trinity Biotech ADR is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Trinity Biotech ADR | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten